Richmond, Jan. 03, 2024 (GLOBE NEWSWIRE) -- According to a research report "Cardiac Marker Testing Market” By Product (Instruments, Reagents and Kits), By Biomarker Type (Troponin1 and T, CK-MB), By Type of Testing (Laboratory Testing, Point Of Care Testing), By Disease (Myocardial Function, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis Others) and Region - Global Forecast to 2030.
Global Cardiac Marker Testing Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 2.45 Billion |
| Market size value in 2030 | USD 6.0 Billion |
| CAGR (2023-2030) | 9.4% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Product, Biomarker Type, Type of Testing, Disease, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3782
TOC Covers in Depth & Breath on Cardiac Marker Testing Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Reagents and Kits, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The global Cardiac Marker Testing market has emerged as a key factor in revolutionizing the treatment for various cardiac diseases and its early diagnosis. It is also effected by the changing lifestyle along with the increase in the rising geriatric population and the growing public investments for supporting the research for cardiac biomarkers has contributed towards the market expansion.
The Cardiac Marker Testing proves to be an important tool when it comes in dealing with the emergency settings where the instant decision making is very critical. The rapid diagnosis assist for the prompt initiation and the appropriate treatment of the same which can save a human life. Also the cardiac markers are able to differentiate between the cardiac and non-cardiac causes of the chest pain and discomfort this can guide in instant treatment as well.
Additionally cardiac markers are able to provide the detailed analysis about the patient’s chances of experiencing the future cardiac events. This assists in the long term risk assessment and planning in addition to guidance to cardiac interventions such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), based on the extent of myocardial damage.
The integration of Point of Care Testing (POCT) in the healthcare settings has created growth opportunity for cardiac markers testing. The POCT allows for the fast assessment of the cardiac markers placed directly beside or in the outpatient settings. Additionally the remote POCT invention has resulted in quick results whichin turn leads to a faster treatment process thus saving both the time and patients life. Additionally this would enable the companies to develop the user friendly testing devices.
Also with the advancements in the personalized medicine and precsion diagnostics has created newer opportunities in the market. The advancements in genomics and the molecular diagnostics allows for the more personalized approach in the cardiovascular care. The cardiac markers can be integrated in the broader molecuelar profiling which can assist in identification of the specific genetic markers associated with the cardiovascular risk and response to the therapy.
Major vendors in the global Cardiac Marker Testing market:
- Abbott Laboratories
- Becton
- BioMérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin
- Dickinson and Company
- F. Hoffmann-La Roche AG
- LSI Medience Corporation
- PerkinElmer, Inc.
- Quidel Corporation
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Tosoh Corporation
Request for Discount @ https://www.marketdigits.com/request/discount/3782
Market Dynamics
Drivers:
- Rise in the number of cancer cases.
- Minimal invasive procedures
- Early detection and accurate diagnosis of the diseases.
- Increase in the healthcare expenditures
- Technical advancements and easy access to the healthcare facilities
Opportunities:
- Advancements in the Cardiac Marker Testing for the infectious disease diagnostics such as the remote biopsy procedures.
- Integration with the 3D printing technologies for creating a patient specific Cardiac Marker Testing.
- Targeted therapies and the biomarker identification.
- Implementation of remote biopsy procedures
- Growing popularity of point of care Cardiac Marker Testing
Rising Demand for Cardiac Marker Testing in Laboratory Testing Type of Testings
Based on the Type of Testing the market is segmented into Laboratory Testing, Point Of Care Testing, Liver Biopsy, Lung Biopsy, Gynaecological Biopsy, Others. The increasing adoption of Cardiac Marker Testing in Laboratory Testing Type of Testings is a significant driver which contributes towards the growth of the segment. The most prominent use of the breast Cardiac Marker Testing is the collection of tissue samples from the identified breast lesion. This collected tissue helps pathologists analyze the cells for signs of malignancy or other abnormalities. Additionally with the integration of AI powered devices it is able to provide the real time guidance during the Cardiac Marker Testing procedures. This leads to the automated needle tracking and its adjustments which is done on the basis of continuous analysis of the imaging data. The feedback improves the accuracy of the needle placements particularly in difficult to reach anatomical locations.
Also with the integration of AI it can assist pathologist in analyzing the biopsy samples more effectively. Tools such as automated image recognition and analysis can help in identifying specific cellular and molecular characteristics thus increasing the diagnostic process which allows faster and accurate interpretation of the results. Additionally AI driven diagnostics can be easily integrated with EHRs thus ensuring the information is available immediately.
North America dominates the market for Cardiac Marker Testing.
North America dominates the global Cardiac Marker Testing market. The growth in the region is attributed to the substantial efforts made by governments and the regulatory bodies which boosts the cancer screening detection in the region. The regional growth is also attributed to the increase in the rate of cardiovascular diseases in the region owing to different factors. Moreover the increasing investments along with the increase in the geriatric population has led to the growth in the region. U.S. leads the North American market closely followed by Canada. Additionally the presence of key market players like Abbott, Pfizer has led to growth in the region. As per the reports by Centers for Disease Control and Prevention- approximately 805,000 Americans have a heart attack and about 655,000 Americans die each year from heart disease
Asia Pacific, exhibits a strong growth potential in the Cardiac Marker Testing market owing to the increasing awareness and accurate diagnosis which is leading to an increase in demand for cardiac marker tests. Also the increasing healthcare expenditure along with the adoption of the advanced medical technologies and tests in the region has contributed towards the growth of the cardiac markers testings. Moreover the support from governments in the region for establishing and setting up the manufacturing plants have contributed towards the growth in the region. China dominates the Asia Pacific market followed by India.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3782
Browse Similar Reports:
Cardiac Biomarker Diagnostic Test Kits Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Cardiac Surgery Instruments Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Intracardiac Echocardiography Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
